Harel Insurance Investments & Financial Services Ltd. Has $4.19 Million Stock Position in Chemed Corporation $CHE

Harel Insurance Investments & Financial Services Ltd. lessened its stake in shares of Chemed Corporation (NYSE:CHE) by 24.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,374 shares of the company’s stock after selling 3,028 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Chemed were worth $4,192,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Acadian Asset Management LLC increased its position in shares of Chemed by 69.3% in the second quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock worth $122,056,000 after acquiring an additional 102,597 shares in the last quarter. Boston Trust Walden Corp boosted its stake in Chemed by 0.4% in the 2nd quarter. Boston Trust Walden Corp now owns 247,434 shares of the company’s stock worth $120,483,000 after purchasing an additional 1,083 shares during the period. AQR Capital Management LLC grew its position in Chemed by 160.9% during the 2nd quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock worth $97,893,000 after purchasing an additional 123,982 shares in the last quarter. Norges Bank acquired a new stake in Chemed during the 2nd quarter valued at $89,388,000. Finally, DekaBank Deutsche Girozentrale lifted its holdings in shares of Chemed by 0.4% in the second quarter. DekaBank Deutsche Girozentrale now owns 155,267 shares of the company’s stock valued at $75,604,000 after purchasing an additional 688 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Royal Bank Of Canada lowered their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $574.25.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 3.29% of the stock is owned by company insiders.

Chemed Trading Down 1.4%

Shares of NYSE:CHE opened at $452.40 on Friday. The firm has a market cap of $6.41 billion, a price-to-earnings ratio of 23.92, a P/E/G ratio of 2.20 and a beta of 0.44. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60. The business has a fifty day simple moving average of $435.69 and a 200 day simple moving average of $444.04.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The firm had revenue of $624.90 million during the quarter, compared to analyst estimates of $626.04 million. During the same period in the previous year, the company earned $5.64 earnings per share. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, sell-side analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s dividend payout ratio (DPR) is presently 12.69%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.